Antiviral therapy delays esophageal variceal bleeding in hepatitis B virus-related cirrhosis

World Journal of Gastroenterology

Volumn 19, Issue 40, 2013, Pages 6849-6856

  Li, Chang Zheng ^a   Cheng, Liu Fang ^b   Li, Qing Shan ^a   Wang, Zhi Qiang ^b   Yan, Jun Hong ^a  

^a Second Artillery General Hospital   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Adefovir; Cirrhosis; Entecavir; Esophageal variceal bleeding; Hepatitis B virus; Lamivudine; Nucleoside analog; Resistance

Indexed keywords

ADEFOVIR; ALANINE AMINOTRANSFERASE; ANTIVIRUS AGENT; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; ENTECAVIR; LAMIVUDINE; PROPRANOLOL; SERUM ALBUMIN; TELBIVUDINE;

ADULT; ANTIVIRAL THERAPY; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DYSPEPSIA; ESOPHAGUS VARICES BLEEDING; FATIGUE; FEMALE; HEADACHE; HEMATOLOGICAL PARAMETERS; HEPATITIS B VIRUS; HUMAN; INSOMNIA; KAPLAN MEIER METHOD; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NAUSEA; PATIENT; PORTAL VEIN BLOOD FLOW; SURVIVAL RATE;

ADEFOVIR; CIRRHOSIS; ENTECAVIR; ESOPHAGEAL VARICEAL BLEEDING; HEPATITIS B VIRUS; LAMIVUDINE; NUCLEOSIDE ANALOG; RESISTANCE;

ADULT; ANTIVIRAL AGENTS; CHI-SQUARE DISTRIBUTION; CHINA; DISEASE PROGRESSION; DRUG RESISTANCE, VIRAL; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEPATITIS B; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER CIRRHOSIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; TERTIARY CARE CENTERS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84886994457     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i40.6849     Document Type: Article

References (26)

1. Fattovich G, Giustina G, Schalm SW, Hadziyannis S, Sanchez-Tapias J, Almasio P, Christensen E, Krogsgaard K, Degos F, Carneiro de Moura M. Occurrence of hepatocellular carcinoma and decompensation in western European patients with cirrhosis type B. The EUROHEP Study Group on Hepatitis B Virus and Cirrhosis. Hepatology 1995; 21: 77-82 [PMID: 7806171 DOI: 10.1002/hep.1840210114]
2. Realdi G, Fattovich G, Hadziyannis S, Schalm SW, Almasio P, Sanchez-Tapias J, Christensen E, Giustina G, Noventa F. Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter study. The Investigators of the European Concerted Action on Viral Hepatitis (EUROHEP). J Hepatol 1994; 21: 656-666 [PMID: 7814813 DOI: 10.1016/S0168-8278(94)80115-0]
3. Shah V, Long KH. Modeling our way toward the optimal management of variceal hemorrhage. Am J Gastroenterol 2004; 99: 1289-1290 [PMID: 15233666]
4. Carbonell N, Pauwels A, Serfaty L, Fourdan O, Lévy VG, Poupon R. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology 2004; 40: 652-659 [PMID: 15349904 DOI: 10.1002/hep.20339]
5. Yao FY, Terrault NA, Freise C, Maslow L, Bass NM. Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation: a comparative study using a matched, untreated cohort. Hepatology 2001; 34: 411-416 [PMID: 11481627 DOI: 10.1053/jhep.2001.26512]
6. Hann HW, Fontana RJ, Wright T, Everson G, Baker A, Schiff ER, Riely C, Anschuetz G, Gardner SD, Brown N, Griffiths D. A United States compassionate use study of lamivudine treatment in nontransplantation candidates with decompensated hepatitis B virus-related cirrhosis. Liver Transpl 2003; 9: 49-56 [PMID: 12514773 DOI: 10.1053/jlts.2003.50005]
7. Wright TL. Clinical trial results and treatment resistance with lamivudine in hepatitis B. Semin Liver Dis 2004; 24 Suppl 1: 31-36 [PMID: 15192799 DOI: 10.1055/s-2004-828676]
8. Hadziyannis SJ, Tassopoulos NC, Heathcote EJ, Chang TT, Kitis G, Rizzetto M, Marcellin P, Lim SG, Goodman Z, Ma J, Brosgart CL, Borroto-Esoda K, Arterburn S, Chuck SL. Longterm therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years. Gastroenterology 2006; 131: 1743-1751 [PMID: 17087951 DOI: 10.1053/j.gastro.2006.09.020]
9. Peters MG, Singer G, Howard T, Jacobsmeyer S, Xiong X, Gibbs CS, Lamy P, Murray A. Fulminant hepatic failure resulting from lamivudine-resistant hepatitis B virus in a renal transplant recipient: durable response after orthotopic liver transplantation on adefovir dipivoxil and hepatitis B immune globulin. Transplantation 1999; 68: 1912-1914 [PMID: 10628774 DOI: 10.1097/00007890-199912270-00017]
10. Koga H, Ide T, Oho K, Kuwahara R, Hino T, Ogata K, Hisamochi A, Tanaka K, Kumashiro R, Toyonaga A, Sata M. Lamivudine treatment-related morphological changes of esophageal varices in patients with liver cirrhosis. Hepatol Res 2007; 37: 503-509 [PMID: 17539992 DOI: 10.1111/j.1872-034X.2007.00087.x]
11. Qureshi W, Adler DG, Davila R, Egan J, Hirota W, Leighton J, Rajan E, Zuckerman MJ, Fanelli R, Wheeler-Harbaugh J, Baron TH, Faigel DO. ASGE Guideline: the role of endoscopy in the management of variceal hemorrhage, updated July 2005. Gastrointest Endosc 2005; 62: 651-655 [PMID: 16246673 DOI: 10.1016/j.gie.2005.07.031]
12. Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology 2007; 46: 922-938 [PMID: 17879356 DOI: 10.1002/hep.21907]
13. de Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2005; 43: 167-176 [PMID: 15925423 DOI: 10.1016/ j.jhep.2005.05.009]
14. Japanese Association of Portal Hypertension. Criteria for record of endoscopic findings of esophagogastric varices. Kanzo 1980; 21: 779-783
15. Turnes J, Garcia-Pagan JC, Abraldes JG, Hernandez-Guerra M, Dell'Era A, Bosch J. Pharmacological reduction of portal pressure and long-term risk of first variceal bleeding in patients with cirrhosis. Am J Gastroenterol 2006; 101: 506-512 [PMID: 16542287 DOI: 10.1111/j.1572-0241.2006.00453.x]
16. Groszmann RJ, Garcia-Tsao G, Bosch J, Grace ND, Burroughs AK, Planas R, Escorsell A, Garcia-Pagan JC, Patch D, Matloff DS, Gao H, Makuch R. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med 2005; 353: 2254-2261 [PMID: 16306522 DOI: 10.1056/ NEJMoa044456]
17. Woods KL, Qureshi WA. Long-term endoscopic management of variceal bleeding. Gastrointest Endosc Clin N Am 1999; 9: 253-270 [PMID: 10333441]
18. Krige JE, Kotze UK, Bornman PC, Shaw JM, Klipin M. Variceal recurrence, rebleeding, and survival after endoscopic injection sclerotherapy in 287 alcoholic cirrhotic patients with bleeding esophageal varices. Ann Surg 2006; 244: 764-770 [PMID: 17060770 DOI: 10.1097/01.sla.0000231704.45005.4e]
19. Li CZ, Cheng LF, Wang ZQ, Gu Y. Attempt of photodynamic therapy on esophageal varices. Lasers Med Sci 2009; 24: 167-171 [PMID: 18270762 DOI: 10.1007/s10103-008-0542-6]
20. Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology 2009; 50: 661-662 [PMID: 19714720 DOI: 10.1002/ hep.23190]
21. European Association For The Study Of The Liver. EASL clinical practice guidelines: Management of chronic hepatitis B virus infection. J Hepatol 2012; 57: 167-185 [PMID: 22436845 DOI: 10.1016/j.jhep.2012.02.010]
22. Liaw YF, Leung N, Kao JH, Piratvisuth T, Gane E, Han KH, Guan R, Lau GK, Locarnini S. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update. Hepatol Int 2008; 2: 263-283 [PMID: 19669255 DOI: 10.1007/s12072-008-9080-3]
23. Chang TT, Liaw YF, Wu SS, Schiff E, Han KH, Lai CL, Safadi R, Lee SS, Halota W, Goodman Z, Chi YC, Zhang H, Hindes R, Iloeje U, Beebe S, Kreter B. Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B. Hepatology 2010; 52: 886-893 [PMID: 20683932 DOI: 10.1002/hep.23785]
24. Wong GL, Chan HL, Mak CH, Lee SK, Ip ZM, Lam AT, Iu HW, Leung JM, Lai JW, Lo AO, Chan HY, Wong VW. Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients with liver cirrhosis. Hepatology 2013 [Epub ahead of print] [PMID: 23389810 DOI: 10.1002/hep.26301]
25. Tenney DJ, Rose RE, Baldick CJ, Pokornowski KA, Eggers BJ, Fang J, Wichroski MJ, Xu D, Yang J, Wilber RB, Colonno RJ. Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy. Hepatology 2009; 49: 1503-1514 [PMID: 19280622 DOI: 10.1002/hep.22841]
26. Yun TJ, Jung JY, Kim CH, Um SH, An H, Seo YS, Kim JD, Yim HJ, Keum B, Kim YS, Jeen YT, Lee HS, Chun HJ, Kim CD, Ryu HS. Treatment strategies using adefovir dipivoxil for individuals with lamivudine-resistant chronic hepatitis B. World J Gastroenterol 2012; 18: 6987-6995 [PMID: 23322998 DOI: 10.3748/wjg.v18.i47.6987]